Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

JanOne Pre-Tax Profit Margin 2010-2024 | JAN

JanOne pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
  
JanOne Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2021-12-31 $0.04B $-0.00B -7.32%
2021-09-30 $0.04B $-0.01B -15.38%
2021-06-30 $0.04B $-0.01B -17.95%
2021-03-31 $0.03B $-0.01B -14.71%
2020-12-31 $0.03B $-0.01B -27.27%
2020-09-30 $0.04B $-0.01B -40.00%
2020-06-30 $0.03B $-0.02B -48.48%
2020-03-31 $0.04B $-0.02B -43.24%
2019-12-31 $0.04B $-0.02B -45.71%
2019-09-30 $0.03B $-0.01B -27.27%
2019-06-30 $0.03B $-0.01B -21.21%
2019-03-31 $0.03B $-0.01B -21.21%
2018-12-31 $0.04B $-0.01B -16.67%
2018-09-30 $0.04B $-0.01B -17.95%
2018-06-30 $0.04B $-0.01B -12.50%
2018-03-31 $0.04B $-0.00B -4.65%
2017-12-31 $0.04B $0.00B 7.32%
2017-09-30 $-0.01B $0.01B -75.00%
2017-06-30 $0.01B $0.01B 75.00%
2017-03-31 $0.02B $0.00B 18.18%
2016-12-31 $0.04B 0 0.00%
2016-09-30 $0.10B $-0.00B -2.91%
2016-06-30 $0.10B $-0.01B -4.81%
2016-03-31 $0.11B $-0.00B -3.67%
2015-12-31 $0.11B $-0.01B -4.46%
2015-09-30 $0.12B $-0.00B -3.39%
2015-06-30 $0.12B $-0.00B -2.44%
2015-03-31 $0.13B $-0.00B -1.59%
2014-12-31 $0.13B $0.00B 0.76%
2014-09-30 $0.13B $0.00B 1.53%
2014-06-30 $0.13B $0.00B 2.27%
2014-03-31 $0.13B $0.00B 2.29%
2013-12-31 $0.13B $0.00B 1.56%
2013-09-30 $0.12B $-0.00B -0.81%
2013-06-30 $0.12B $-0.00B -2.54%
2013-03-31 $0.12B $-0.00B -3.45%
2012-12-31 $0.12B $-0.00B -3.48%
2012-09-30 $0.12B $-0.00B -0.86%
2012-06-30 $0.12B $0.00B 2.44%
2012-03-31 $0.13B $0.01B 3.97%
2011-12-31 $0.13B $0.01B 4.72%
2011-09-30 $0.12B $0.01B 5.65%
2011-06-30 $0.12B $0.01B 4.35%
2011-03-31 $0.11B $0.00B 3.64%
2010-12-31 $0.11B $0.00B 2.80%
2010-09-30 $0.11B $0.00B 0.94%
2010-06-30 $0.11B $0.00B 0.95%
2010-03-31 $0.10B 0 0.00%
2009-12-31 $0.10B $-0.00B -1.98%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.019B $0.040B
JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021. JanOne is dedicated to funding resources toward innovation, technology, and education for PAD, associated vascular conditions and neuropathic pain. JanOne continues to operate its legacy businesses under their current brand names, which are undergoing review to determine appropriate strategic alternatives.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.125B 32.58
Chugai Pharmaceutical (CHGCY) Japan $60.930B 27.24
Takeda Pharmaceutical (TAK) Japan $41.491B 8.40
Merck (MKGAF) Germany $21.325B 20.68
Astellas Pharma (ALPMY) Japan $17.744B 28.01
Sandoz Group AG (SDZNY) Switzerland $15.663B 0.00
Neurocrine Biosciences (NBIX) United States $13.911B 38.08
United Therapeutics (UTHR) United States $13.796B 14.71
Shionogi (SGIOY) Japan $11.343B 9.86
Catalent (CTLT) United States $10.227B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.342B 0.00
Ionis Pharmaceuticals (IONS) United States $6.656B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.529B 7.17
Revolution Medicines (RVMD) United States $6.091B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.790B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $4.837B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.486B 0.00
Corcept Therapeutics (CORT) United States $3.175B 28.77
Arrowhead Pharmaceuticals (ARWR) United States $3.114B 0.00
Dyne Therapeutics (DYN) United States $2.979B 0.00
PTC Therapeutics (PTCT) United States $2.378B 0.00
Indivior (INDV) United States $2.104B 9.97
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.083B 11.84
Evotec AG (EVO) Germany $1.825B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.808B 17.60
NewAmsterdam Pharma (NAMS) Netherlands $1.800B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.747B 0.00
Soleno Therapeutics (SLNO) United States $1.404B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.397B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.323B 0.00
Ardelyx (ARDX) United States $1.238B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.169B 0.00
Xencor (XNCR) United States $1.148B 0.00
4D Molecular Therapeutics (FDMT) United States $1.078B 0.00
Collegium Pharmaceutical (COLL) United States $1.059B 6.33
Ocular Therapeutix (OCUL) United States $1.036B 0.00
Enliven Therapeutics (ELVN) United States $1.014B 0.00
Pacira BioSciences (PCRX) United States $1.008B 9.58
Ironwood Pharmaceuticals (IRWD) United States $0.956B 14.90
Cronos Group (CRON) Canada $0.887B 0.00
ARS Pharmaceuticals (SPRY) United States $0.881B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.862B 0.00
USANA Health Sciences (USNA) United States $0.857B 14.01
Relay Therapeutics (RLAY) United States $0.832B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.780B 0.00
Harrow (HROW) United States $0.764B 0.00
Exscientia (EXAI) United Kingdom $0.649B 0.00
Sage Therapeutics (SAGE) United States $0.639B 0.00
Savara (SVRA) United States $0.598B 0.00
Siga Technologies (SIGA) United States $0.550B 7.04
Silence Therapeutics (SLN) United Kingdom $0.538B 0.00
ProKidney (PROK) United States $0.534B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.531B 0.00
Cassava Sciences (SAVA) United States $0.517B 0.00
KalVista Pharmaceuticals (KALV) United States $0.494B 0.00
Lexeo Therapeutics (LXEO) United States $0.491B 0.00
Larimar Therapeutics (LRMR) United States $0.487B 0.00
Altimmune (ALT) United States $0.468B 0.00
Bioventus (BVS) United States $0.466B 17.85
Esperion Therapeutics (ESPR) United States $0.447B 0.00
Verve Therapeutics (VERV) United States $0.432B 0.00
OmniAb (OABI) United States $0.429B 0.00
Heron Therapeutics (HRTX) United States $0.417B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.414B 0.00
Lyell Immunopharma (LYEL) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.370B 69.75
Korro Bio (KRRO) United States $0.355B 0.00
Tourmaline Bio (TRML) United States $0.329B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.318B 0.00
Xeris Biopharma Holdings (XERS) United States $0.308B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.86
Enanta Pharmaceuticals (ENTA) United States $0.278B 0.00
Nanobiotix S.A (NBTX) France $0.254B 0.00
Black Diamond Therapeutics (BDTX) United States $0.250B 0.00
Foghorn Therapeutics (FHTX) United States $0.239B 0.00
Nektar Therapeutics (NKTR) United States $0.239B 0.00
Aquestive Therapeutics (AQST) United States $0.219B 0.00
Fractyl Health (GUTS) United States $0.214B 0.00
ESSA Pharma (EPIX) Canada $0.212B 0.00
Profound Medical (PROF) Canada $0.212B 0.00
Eliem Therapeutics (ELYM) United States $0.204B 0.00
Avita Medical (RCEL) United States $0.201B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Prelude Therapeutics (PRLD) United States $0.199B 0.00
Akebia Therapeutics (AKBA) United States $0.198B 0.00
Elite Pharmaceuticals (ELTP) United States $0.197B 18.45
Century Therapeutics (IPSC) United States $0.192B 0.00
Aldeyra Therapeutics (ALDX) United States $0.190B 0.00
Acrivon Therapeutics (ACRV) United States $0.190B 0.00
Zevra Therapeutics (ZVRA) United States $0.180B 0.00
Incannex Healthcare (IXHL) Australia $0.174B 0.00
Pyxis Oncology (PYXS) United States $0.170B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Metagenomi (MGX) United States $0.146B 0.00
CytoDyn (CYDY) United States $0.138B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.136B 0.00
MediWound (MDWD) Israel $0.135B 0.00
Context Therapeutics (CNTX) United States $0.134B 0.00
Galectin Therapeutics (GALT) United States $0.134B 0.00
Cardiol Therapeutics (CRDL) Canada $0.132B 0.00
Assertio Holdings (ASRT) United States $0.129B 5.91
Amylyx Pharmaceuticals (AMLX) United States $0.120B 8.05
OptiNose (OPTN) United States $0.119B 0.00
Regulus Therapeutics (RGLS) United States $0.118B 0.00
VAXART, INC (VXRT) United States $0.114B 0.00
Telomir Pharmaceuticals (TELO) United States $0.111B 0.00
Karyopharm Therapeutics (KPTI) United States $0.103B 0.00
Journey Medical (DERM) United States $0.103B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Citius Pharmaceuticals (CTXR) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.080B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.073B 1.03
CASI Pharmaceuticals (CASI) China $0.070B 0.00
ProPhase Labs (PRPH) United States $0.069B 0.00
FibroGen (FGEN) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Carisma Therapeutics (CARM) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.051B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
Conduit Pharmaceuticals (CDT) United States $0.047B 0.00
Tempest Therapeutics (TPST) United States $0.047B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.046B 0.00
Inotiv (NOTV) United States $0.044B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.042B 0.00
Lipocine (LPCN) United States $0.042B 0.00
DURECT (DRRX) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Natural Alternatives (NAII) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
NRx Pharmaceuticals (NRXP) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
BioVie (BIVI) United States $0.025B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Oncternal Therapeutics (ONCT) United States $0.021B 0.00
Gain Therapeutics (GANX) United States $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
Viracta Therapeutics (VIRX) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.72
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Unicycive Therapeutics (UNCY) United States $0.018B 0.00
SHINECO (SISI) China $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Talphera (TLPH) United States $0.016B 0.00
Cosmos Health (COSM) Greece $0.015B 0.00
Mannatech (MTEX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Universe Pharmaceuticals INC (UPC) China $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.81
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 30.48